Rank | Gene Set | Z-score |
---|---|---|
1 | short-term memory (GO:0007614) | 5.31523302 |
2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.13815167 |
3 | neuron cell-cell adhesion (GO:0007158) | 5.12477118 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.93631951 |
5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.85972836 |
6 | neuronal action potential (GO:0019228) | 4.83050340 |
7 | synaptic vesicle exocytosis (GO:0016079) | 4.81311891 |
8 | protein localization to synapse (GO:0035418) | 4.76108137 |
9 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.75101748 |
10 | response to pheromone (GO:0019236) | 4.74266416 |
11 | cerebellar granule cell differentiation (GO:0021707) | 4.37603510 |
12 | glutamate secretion (GO:0014047) | 4.35684556 |
13 | vocalization behavior (GO:0071625) | 4.32924280 |
14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.26420430 |
15 | presynaptic membrane organization (GO:0097090) | 4.18500431 |
16 | C4-dicarboxylate transport (GO:0015740) | 4.18342794 |
17 | urinary tract smooth muscle contraction (GO:0014848) | 4.17288168 |
18 | presynaptic membrane assembly (GO:0097105) | 4.13993706 |
19 | neuronal action potential propagation (GO:0019227) | 4.12585666 |
20 | membrane depolarization during action potential (GO:0086010) | 4.09411528 |
21 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.08199451 |
22 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.05320900 |
23 | synaptic vesicle maturation (GO:0016188) | 4.04790369 |
24 | nucleobase catabolic process (GO:0046113) | 4.02747998 |
25 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.98403624 |
26 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.96324360 |
27 | behavioral response to nicotine (GO:0035095) | 3.91332749 |
28 | response to histamine (GO:0034776) | 3.83443198 |
29 | * regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.83355086 |
30 | proline transport (GO:0015824) | 3.82524730 |
31 | mating behavior (GO:0007617) | 3.80286061 |
32 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.78496162 |
33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.77397261 |
34 | cell migration in hindbrain (GO:0021535) | 3.71669373 |
35 | cerebellar Purkinje cell layer development (GO:0021680) | 3.70940835 |
36 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.64402606 |
37 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.64402606 |
38 | negative regulation of microtubule polymerization (GO:0031115) | 3.62494289 |
39 | gamma-aminobutyric acid transport (GO:0015812) | 3.61754472 |
40 | neurotransmitter secretion (GO:0007269) | 3.61419057 |
41 | regulation of synaptic vesicle transport (GO:1902803) | 3.61366733 |
42 | retina layer formation (GO:0010842) | 3.59181387 |
43 | detection of temperature stimulus (GO:0016048) | 3.57304434 |
44 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.56339480 |
45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.56187987 |
46 | neurofilament cytoskeleton organization (GO:0060052) | 3.54204309 |
47 | cellular potassium ion homeostasis (GO:0030007) | 3.53985636 |
48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.52505199 |
49 | * neuron-neuron synaptic transmission (GO:0007270) | 3.51637045 |
50 | neurotransmitter catabolic process (GO:0042135) | 3.46688384 |
51 | positive regulation of action potential (GO:0045760) | 3.45153700 |
52 | cell differentiation in hindbrain (GO:0021533) | 3.45129610 |
53 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.45068253 |
54 | layer formation in cerebral cortex (GO:0021819) | 3.44837581 |
55 | behavioral response to cocaine (GO:0048148) | 3.43363397 |
56 | negative regulation of dendrite development (GO:2000171) | 3.40035525 |
57 | * synaptic transmission, glutamatergic (GO:0035249) | 3.39753302 |
58 | adult walking behavior (GO:0007628) | 3.38890644 |
59 | neuron recognition (GO:0008038) | 3.36827664 |
60 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.36293035 |
61 | retinal ganglion cell axon guidance (GO:0031290) | 3.35341848 |
62 | auditory behavior (GO:0031223) | 3.28036342 |
63 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.25198908 |
64 | synapse assembly (GO:0007416) | 3.24198950 |
65 | anterograde axon cargo transport (GO:0008089) | 3.23148495 |
66 | regulation of dopamine secretion (GO:0014059) | 3.20193767 |
67 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.18606064 |
68 | * membrane depolarization (GO:0051899) | 3.18059743 |
69 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.16493108 |
70 | positive regulation of synapse assembly (GO:0051965) | 3.15064951 |
71 | transmission of nerve impulse (GO:0019226) | 3.14056625 |
72 | synaptic transmission, cholinergic (GO:0007271) | 3.12943123 |
73 | innervation (GO:0060384) | 3.11952715 |
74 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.11217123 |
75 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.11069429 |
76 | long-term memory (GO:0007616) | 3.10442938 |
77 | neurotransmitter transport (GO:0006836) | 3.09905822 |
78 | axon cargo transport (GO:0008088) | 3.08301169 |
79 | locomotory exploration behavior (GO:0035641) | 3.06261607 |
80 | postsynaptic membrane organization (GO:0001941) | 3.06128079 |
81 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.05831998 |
82 | * glutamate receptor signaling pathway (GO:0007215) | 3.05344852 |
83 | protein localization to cilium (GO:0061512) | 3.04863412 |
84 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.04566709 |
85 | neuromuscular synaptic transmission (GO:0007274) | 3.04304720 |
86 | action potential (GO:0001508) | 3.02487919 |
87 | regulation of action potential (GO:0098900) | 3.01804740 |
88 | * membrane hyperpolarization (GO:0060081) | 2.98999846 |
89 | mitochondrion transport along microtubule (GO:0047497) | 2.98808707 |
90 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.98808707 |
91 | axon regeneration (GO:0031103) | 2.98760587 |
92 | potassium ion homeostasis (GO:0055075) | 2.96733034 |
93 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.95720007 |
94 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.94261272 |
95 | negative regulation of heart rate (GO:0010459) | 2.94147500 |
96 | regulation of vesicle fusion (GO:0031338) | 2.94066681 |
97 | chemosensory behavior (GO:0007635) | 2.93467403 |
98 | regulation of neurotransmitter secretion (GO:0046928) | 2.91860705 |
99 | synaptic vesicle endocytosis (GO:0048488) | 2.91723827 |
100 | sodium ion export (GO:0071436) | 2.91581191 |
101 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.91406240 |
102 | positive regulation of muscle hypertrophy (GO:0014742) | 2.91406240 |
103 | neuronal ion channel clustering (GO:0045161) | 2.90606168 |
104 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.90006209 |
105 | establishment of mitochondrion localization (GO:0051654) | 2.89936108 |
106 | axon development (GO:0061564) | 2.89443731 |
107 | positive regulation of vesicle fusion (GO:0031340) | 2.88911859 |
108 | calcium ion-dependent exocytosis (GO:0017156) | 2.86774036 |
109 | prepulse inhibition (GO:0060134) | 2.86076849 |
110 | cellular sodium ion homeostasis (GO:0006883) | 2.85967506 |
111 | response to auditory stimulus (GO:0010996) | 2.85783351 |
112 | * synaptic transmission (GO:0007268) | 2.85030743 |
113 | * adult behavior (GO:0030534) | 2.85027798 |
114 | membrane repolarization (GO:0086009) | 2.84077647 |
115 | positive regulation of membrane potential (GO:0045838) | 2.82022314 |
116 | regulation of dopamine metabolic process (GO:0042053) | 2.81724676 |
117 | regulation of catecholamine metabolic process (GO:0042069) | 2.81724676 |
118 | dendrite morphogenesis (GO:0048813) | 2.80030785 |
119 | startle response (GO:0001964) | 2.79414223 |
120 | * positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.78978204 |
121 | regulation of neurotransmitter levels (GO:0001505) | 2.78847757 |
122 | exploration behavior (GO:0035640) | 2.78686500 |
123 | neuromuscular process controlling posture (GO:0050884) | 2.77566070 |
124 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.76477166 |
125 | glycine transport (GO:0015816) | 2.74440105 |
126 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.74163855 |
127 | tachykinin receptor signaling pathway (GO:0007217) | 2.73943318 |
128 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.73554314 |
129 | synaptic vesicle transport (GO:0048489) | 2.73453022 |
130 | establishment of synaptic vesicle localization (GO:0097480) | 2.73453022 |
131 | membrane assembly (GO:0071709) | 2.72651921 |
132 | response to cocaine (GO:0042220) | 2.71154996 |
133 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.70466254 |
134 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.70466254 |
135 | regulation of synapse structural plasticity (GO:0051823) | 2.70291542 |
136 | glycosphingolipid biosynthetic process (GO:0006688) | 2.70130939 |
137 | axonal fasciculation (GO:0007413) | 2.68795019 |
138 | regulation of neurotransmitter transport (GO:0051588) | 2.67567310 |
139 | sodium ion transmembrane transport (GO:0035725) | 2.67552096 |
140 | detection of calcium ion (GO:0005513) | 2.67093814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.01863121 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.02473619 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03753852 |
4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02306552 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.01940706 |
6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.95855149 |
7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.94273098 |
8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.78359736 |
9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74942012 |
10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.62359020 |
11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59697821 |
12 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59697821 |
13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50797130 |
14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50534874 |
15 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.46644509 |
16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42681987 |
17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.42258914 |
18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35252592 |
19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31659620 |
20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.23985014 |
21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15734410 |
22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12488835 |
23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11491864 |
24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06121529 |
25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.03572724 |
26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.02002122 |
27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00955482 |
28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98138487 |
29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.97818005 |
30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.96596417 |
31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94955922 |
32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81998797 |
33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77432171 |
34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76574683 |
35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72936378 |
36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68040643 |
37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65010596 |
38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64589743 |
39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63740075 |
40 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61165643 |
41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.60195051 |
42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55050243 |
43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53796887 |
44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.52915173 |
45 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51051160 |
46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.50994730 |
47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.46061901 |
48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44708414 |
49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.44514056 |
50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43763341 |
51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42789582 |
52 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42419940 |
53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41549311 |
54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41492874 |
55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38480109 |
56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34795625 |
57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33428604 |
58 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.32109394 |
59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32077180 |
60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29535194 |
61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29393901 |
62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27751981 |
63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27690924 |
64 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27569639 |
65 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.26984265 |
66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23213914 |
67 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23096163 |
68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21808482 |
69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20218252 |
70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19378613 |
71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17845703 |
72 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15900529 |
73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14691223 |
74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14678604 |
75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14074971 |
76 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13540539 |
77 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12144552 |
78 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11976706 |
79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11803027 |
80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08924531 |
81 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08718734 |
82 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08372477 |
83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07319634 |
84 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06974121 |
85 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06049752 |
86 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.05766288 |
87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03771694 |
88 | JUN_21703547_ChIP-Seq_K562_Human | 1.03685519 |
89 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03037518 |
90 | AR_19668381_ChIP-Seq_PC3_Human | 1.02276725 |
91 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01253106 |
92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01178669 |
93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01178669 |
94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00707742 |
95 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99521466 |
96 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.99094274 |
97 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98812371 |
98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98812371 |
99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98094951 |
100 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97351234 |
101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97334819 |
102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97037034 |
103 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.96997697 |
104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96537466 |
105 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.96011280 |
106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95227585 |
107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95138568 |
108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91357141 |
109 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91194665 |
110 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90071613 |
111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89723978 |
112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89505046 |
113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88458477 |
114 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86966231 |
115 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.86871991 |
116 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86674799 |
117 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86319055 |
118 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.86218431 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001968_abnormal_touch/_nociception | 5.94526445 |
2 | MP0002736_abnormal_nociception_after | 5.84120124 |
3 | * MP0002735_abnormal_chemical_nociception | 4.76385585 |
4 | MP0003880_abnormal_central_pattern | 4.02666071 |
5 | MP0004859_abnormal_synaptic_plasticity | 3.77779866 |
6 | MP0002734_abnormal_mechanical_nocicepti | 3.57500635 |
7 | MP0002733_abnormal_thermal_nociception | 3.42599280 |
8 | MP0004270_analgesia | 3.38743614 |
9 | * MP0003635_abnormal_synaptic_transmissio | 3.02631663 |
10 | MP0006276_abnormal_autonomic_nervous | 3.01361331 |
11 | * MP0001970_abnormal_pain_threshold | 2.86140049 |
12 | * MP0002272_abnormal_nervous_system | 2.83564948 |
13 | MP0005423_abnormal_somatic_nervous | 2.74279298 |
14 | MP0001986_abnormal_taste_sensitivity | 2.64882517 |
15 | MP0009046_muscle_twitch | 2.63997546 |
16 | MP0002064_seizures | 2.59738182 |
17 | MP0009745_abnormal_behavioral_response | 2.44141274 |
18 | MP0004858_abnormal_nervous_system | 2.36823151 |
19 | MP0002063_abnormal_learning/memory/cond | 2.35621096 |
20 | MP0002067_abnormal_sensory_capabilities | 2.33584304 |
21 | MP0002572_abnormal_emotion/affect_behav | 2.18773001 |
22 | MP0002184_abnormal_innervation | 2.12286564 |
23 | MP0001486_abnormal_startle_reflex | 1.99437032 |
24 | MP0001440_abnormal_grooming_behavior | 1.89877017 |
25 | MP0003329_amyloid_beta_deposits | 1.72250037 |
26 | MP0001984_abnormal_olfaction | 1.70526090 |
27 | MP0000778_abnormal_nervous_system | 1.69299404 |
28 | MP0005551_abnormal_eye_electrophysiolog | 1.68747845 |
29 | MP0004811_abnormal_neuron_physiology | 1.57080192 |
30 | MP0001529_abnormal_vocalization | 1.55876462 |
31 | MP0000955_abnormal_spinal_cord | 1.55767963 |
32 | MP0002557_abnormal_social/conspecific_i | 1.49009892 |
33 | MP0003121_genomic_imprinting | 1.48435855 |
34 | MP0002882_abnormal_neuron_morphology | 1.47211046 |
35 | MP0001501_abnormal_sleep_pattern | 1.45442885 |
36 | MP0004142_abnormal_muscle_tone | 1.41519172 |
37 | MP0004924_abnormal_behavior | 1.39312294 |
38 | MP0005386_behavior/neurological_phenoty | 1.39312294 |
39 | MP0001905_abnormal_dopamine_level | 1.32072777 |
40 | MP0003122_maternal_imprinting | 1.27065113 |
41 | MP0002229_neurodegeneration | 1.23650600 |
42 | MP0002066_abnormal_motor_capabilities/c | 1.23378989 |
43 | MP0008569_lethality_at_weaning | 1.21773161 |
44 | MP0002751_abnormal_autonomic_nervous | 1.21075447 |
45 | MP0005645_abnormal_hypothalamus_physiol | 1.19916071 |
46 | MP0004742_abnormal_vestibular_system | 1.13607847 |
47 | MP0005171_absent_coat_pigmentation | 1.12760527 |
48 | MP0002752_abnormal_somatic_nervous | 1.10942662 |
49 | MP0001188_hyperpigmentation | 1.07078755 |
50 | MP0003634_abnormal_glial_cell | 1.06527138 |
51 | MP0000920_abnormal_myelination | 1.06223011 |
52 | MP0002837_dystrophic_cardiac_calcinosis | 1.02230106 |
53 | MP0002638_abnormal_pupillary_reflex | 1.02133885 |
54 | MP0005187_abnormal_penis_morphology | 0.99136462 |
55 | MP0000751_myopathy | 0.98467551 |
56 | MP0003633_abnormal_nervous_system | 0.98210024 |
57 | MP0006072_abnormal_retinal_apoptosis | 0.96086242 |
58 | MP0001502_abnormal_circadian_rhythm | 0.96063419 |
59 | MP0006035_abnormal_mitochondrial_morpho | 0.94963745 |
60 | MP0003879_abnormal_hair_cell | 0.94527823 |
61 | MP0003136_yellow_coat_color | 0.93311459 |
62 | MP0008877_abnormal_DNA_methylation | 0.91367476 |
63 | MP0003631_nervous_system_phenotype | 0.90528974 |
64 | MP0002822_catalepsy | 0.89524569 |
65 | MP0005253_abnormal_eye_physiology | 0.89094747 |
66 | MP0002909_abnormal_adrenal_gland | 0.86020825 |
67 | MP0009780_abnormal_chondrocyte_physiolo | 0.85417016 |
68 | MP0002152_abnormal_brain_morphology | 0.84084153 |
69 | MP0000534_abnormal_ureter_morphology | 0.83916797 |
70 | MP0004885_abnormal_endolymph | 0.83797399 |
71 | MP0001485_abnormal_pinna_reflex | 0.83074476 |
72 | MP0001963_abnormal_hearing_physiology | 0.80217418 |
73 | MP0002090_abnormal_vision | 0.79809495 |
74 | MP0004133_heterotaxia | 0.79260095 |
75 | MP0000604_amyloidosis | 0.77706523 |
76 | MP0003861_abnormal_nervous_system | 0.74395084 |
77 | MP0001270_distended_abdomen | 0.74364016 |
78 | MP0005646_abnormal_pituitary_gland | 0.73890668 |
79 | MP0005499_abnormal_olfactory_system | 0.73423344 |
80 | MP0005394_taste/olfaction_phenotype | 0.73423344 |
81 | MP0004147_increased_porphyrin_level | 0.73312320 |
82 | MP0001177_atelectasis | 0.72674310 |
83 | MP0003632_abnormal_nervous_system | 0.72353228 |
84 | MP0009379_abnormal_foot_pigmentation | 0.71605363 |
85 | MP0008874_decreased_physiological_sensi | 0.70871297 |
86 | MP0001664_abnormal_digestion | 0.70010537 |
87 | MP0004085_abnormal_heartbeat | 0.68830658 |
88 | MP0004145_abnormal_muscle_electrophysio | 0.67488488 |
89 | MP0001299_abnormal_eye_distance/ | 0.66700548 |
90 | MP0003137_abnormal_impulse_conducting | 0.66420736 |
91 | MP0010386_abnormal_urinary_bladder | 0.66017558 |
92 | MP0000579_abnormal_nail_morphology | 0.65769863 |
93 | MP0002069_abnormal_eating/drinking_beha | 0.65418418 |
94 | MP0004043_abnormal_pH_regulation | 0.65243292 |
95 | MP0003011_delayed_dark_adaptation | 0.64775520 |
96 | MP0008872_abnormal_physiological_respon | 0.64283834 |
97 | MP0003938_abnormal_ear_development | 0.63430953 |
98 | MP0000569_abnormal_digit_pigmentation | 0.62765341 |
99 | MP0003890_abnormal_embryonic-extraembry | 0.62472583 |
100 | MP0000631_abnormal_neuroendocrine_gland | 0.61782832 |
101 | MP0002876_abnormal_thyroid_physiology | 0.61016512 |
102 | MP0003787_abnormal_imprinting | 0.60213642 |
103 | MP0005195_abnormal_posterior_eye | 0.60168486 |
104 | MP0005595_abnormal_vascular_smooth | 0.59891057 |
105 | MP0004215_abnormal_myocardial_fiber | 0.58875539 |
106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.58581132 |
107 | MP0000747_muscle_weakness | 0.56970455 |
108 | MP0005535_abnormal_body_temperature | 0.56745737 |
109 | MP0001943_abnormal_respiration | 0.54880168 |
110 | MP0002282_abnormal_trachea_morphology | 0.54763071 |
111 | MP0004036_abnormal_muscle_relaxation | 0.53611576 |
112 | MP0008260_abnormal_autophagy | 0.52928793 |
113 | MP0002081_perinatal_lethality | 0.52323669 |
114 | MP0002082_postnatal_lethality | 0.52225809 |
115 | MP0010770_preweaning_lethality | 0.52225809 |
116 | MP0002653_abnormal_ependyma_morphology | 0.52200010 |
117 | MP0005409_darkened_coat_color | 0.50818193 |
118 | MP0000538_abnormal_urinary_bladder | 0.50276215 |
119 | MP0005083_abnormal_biliary_tract | 0.47369799 |
120 | MP0008789_abnormal_olfactory_epithelium | 0.47054414 |
121 | MP0000026_abnormal_inner_ear | 0.46439874 |
122 | MP0001348_abnormal_lacrimal_gland | 0.46292459 |
123 | MP0008961_abnormal_basal_metabolism | 0.43781546 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.30228128 |
2 | Myokymia (HP:0002411) | 5.21289701 |
3 | Focal seizures (HP:0007359) | 4.88613643 |
4 | Atonic seizures (HP:0010819) | 4.73821469 |
5 | Ulnar claw (HP:0001178) | 4.59442648 |
6 | Febrile seizures (HP:0002373) | 4.29112784 |
7 | Insidious onset (HP:0003587) | 3.97007678 |
8 | Termporal pattern (HP:0011008) | 3.97007678 |
9 | Pheochromocytoma (HP:0002666) | 3.90110944 |
10 | Epileptic encephalopathy (HP:0200134) | 3.82317561 |
11 | Absence seizures (HP:0002121) | 3.77325600 |
12 | Dialeptic seizures (HP:0011146) | 3.75455265 |
13 | Action tremor (HP:0002345) | 3.66606428 |
14 | Visual hallucinations (HP:0002367) | 3.66212547 |
15 | Progressive cerebellar ataxia (HP:0002073) | 3.54966569 |
16 | Neuroendocrine neoplasm (HP:0100634) | 3.52414540 |
17 | Limb dystonia (HP:0002451) | 3.45607843 |
18 | Dysdiadochokinesis (HP:0002075) | 3.44454661 |
19 | Ankle clonus (HP:0011448) | 3.28454187 |
20 | Abnormality of pain sensation (HP:0010832) | 3.25660217 |
21 | Impaired pain sensation (HP:0007328) | 3.25660217 |
22 | Supranuclear gaze palsy (HP:0000605) | 3.20645642 |
23 | Dysautonomia (HP:0002459) | 3.18435947 |
24 | Generalized tonic-clonic seizures (HP:0002069) | 3.16434736 |
25 | Failure to thrive in infancy (HP:0001531) | 3.04018473 |
26 | Status epilepticus (HP:0002133) | 2.96580792 |
27 | Intention tremor (HP:0002080) | 2.96087723 |
28 | Congenital stationary night blindness (HP:0007642) | 2.93259554 |
29 | Progressive inability to walk (HP:0002505) | 2.90969273 |
30 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.87078789 |
31 | Hypoplasia of the brainstem (HP:0002365) | 2.87078789 |
32 | Retinal dysplasia (HP:0007973) | 2.80645426 |
33 | Abnormality of the corticospinal tract (HP:0002492) | 2.77787041 |
34 | Abnormal eating behavior (HP:0100738) | 2.70994453 |
35 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.69046234 |
36 | Spastic gait (HP:0002064) | 2.67577561 |
37 | Polyphagia (HP:0002591) | 2.66562859 |
38 | Truncal ataxia (HP:0002078) | 2.64548598 |
39 | Dysmetric saccades (HP:0000641) | 2.57483800 |
40 | Nephrogenic diabetes insipidus (HP:0009806) | 2.57261151 |
41 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.56548909 |
42 | Hypoventilation (HP:0002791) | 2.55613135 |
43 | Myotonia (HP:0002486) | 2.53406423 |
44 | Steppage gait (HP:0003376) | 2.53387228 |
45 | Abnormal hair whorl (HP:0010721) | 2.50851787 |
46 | Hammertoe (HP:0001765) | 2.45388894 |
47 | Impaired smooth pursuit (HP:0007772) | 2.45004145 |
48 | Genital tract atresia (HP:0001827) | 2.42309469 |
49 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.39723423 |
50 | Central scotoma (HP:0000603) | 2.39520352 |
51 | Amblyopia (HP:0000646) | 2.38621488 |
52 | Urinary urgency (HP:0000012) | 2.36757360 |
53 | Vaginal atresia (HP:0000148) | 2.35935527 |
54 | Postural tremor (HP:0002174) | 2.32948959 |
55 | Acute necrotizing encephalopathy (HP:0006965) | 2.31597286 |
56 | Mutism (HP:0002300) | 2.31251082 |
57 | Horizontal nystagmus (HP:0000666) | 2.30719699 |
58 | Inability to walk (HP:0002540) | 2.30369385 |
59 | Gait imbalance (HP:0002141) | 2.27591945 |
60 | Lower limb muscle weakness (HP:0007340) | 2.26483230 |
61 | Progressive macrocephaly (HP:0004481) | 2.26374063 |
62 | Abnormality of the vocal cords (HP:0008777) | 2.23860309 |
63 | Onion bulb formation (HP:0003383) | 2.23552155 |
64 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.22511028 |
65 | Pancreatic fibrosis (HP:0100732) | 2.20918638 |
66 | True hermaphroditism (HP:0010459) | 2.15417825 |
67 | Foot dorsiflexor weakness (HP:0009027) | 2.15115088 |
68 | Broad-based gait (HP:0002136) | 2.15023322 |
69 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.14120108 |
70 | Hemiplegia (HP:0002301) | 2.13371981 |
71 | Abnormality of macular pigmentation (HP:0008002) | 2.10187630 |
72 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.09947302 |
73 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09713858 |
74 | Hyperventilation (HP:0002883) | 2.07101699 |
75 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.06866688 |
76 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.06508589 |
77 | Molar tooth sign on MRI (HP:0002419) | 2.06292535 |
78 | Abnormality of midbrain morphology (HP:0002418) | 2.06292535 |
79 | EEG with generalized epileptiform discharges (HP:0011198) | 2.05929205 |
80 | Neurofibrillary tangles (HP:0002185) | 2.05257010 |
81 | Epileptiform EEG discharges (HP:0011182) | 2.04406915 |
82 | Hypothermia (HP:0002045) | 2.04069382 |
83 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.02544071 |
84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.02544071 |
85 | Esotropia (HP:0000565) | 2.02518470 |
86 | Lissencephaly (HP:0001339) | 2.01894036 |
87 | Pachygyria (HP:0001302) | 2.01787554 |
88 | Absent speech (HP:0001344) | 2.01766547 |
89 | Peripheral hypomyelination (HP:0007182) | 2.00964582 |
90 | Pancreatic cysts (HP:0001737) | 2.00812364 |
91 | Split foot (HP:0001839) | 2.00148215 |
92 | Specific learning disability (HP:0001328) | 1.97804362 |
93 | Type II lissencephaly (HP:0007260) | 1.97300865 |
94 | Depression (HP:0000716) | 1.95687896 |
95 | Impaired social interactions (HP:0000735) | 1.95331382 |
96 | Abnormal social behavior (HP:0012433) | 1.95331382 |
97 | Scanning speech (HP:0002168) | 1.94664126 |
98 | Sensory axonal neuropathy (HP:0003390) | 1.94241734 |
99 | Gaze-evoked nystagmus (HP:0000640) | 1.94081399 |
100 | Poor eye contact (HP:0000817) | 1.93549822 |
101 | Genetic anticipation (HP:0003743) | 1.93362551 |
102 | Abnormality of binocular vision (HP:0011514) | 1.93161043 |
103 | Diplopia (HP:0000651) | 1.93161043 |
104 | Oligodactyly (hands) (HP:0001180) | 1.92532353 |
105 | Dysmetria (HP:0001310) | 1.91801848 |
106 | Drooling (HP:0002307) | 1.90351462 |
107 | Excessive salivation (HP:0003781) | 1.90351462 |
108 | Medial flaring of the eyebrow (HP:0010747) | 1.90125410 |
109 | Abnormality of the foot musculature (HP:0001436) | 1.89522285 |
110 | Severe visual impairment (HP:0001141) | 1.89178023 |
111 | Hemiparesis (HP:0001269) | 1.88516254 |
112 | Nephronophthisis (HP:0000090) | 1.88075835 |
113 | Hypsarrhythmia (HP:0002521) | 1.87237612 |
114 | Abnormality of the parathyroid morphology (HP:0011766) | 1.87083489 |
115 | Congenital primary aphakia (HP:0007707) | 1.86037437 |
116 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.85328367 |
117 | Akinesia (HP:0002304) | 1.82717066 |
118 | Distal sensory impairment (HP:0002936) | 1.82233004 |
119 | Anxiety (HP:0000739) | 1.80740207 |
120 | Postural instability (HP:0002172) | 1.80427810 |
121 | Agitation (HP:0000713) | 1.79902439 |
122 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79644668 |
123 | Optic nerve hypoplasia (HP:0000609) | 1.77914431 |
124 | Cutaneous finger syndactyly (HP:0010554) | 1.77552917 |
125 | Postaxial hand polydactyly (HP:0001162) | 1.75402994 |
126 | Poor coordination (HP:0002370) | 1.72472180 |
127 | Calf muscle hypertrophy (HP:0008981) | 1.67151032 |
128 | Abnormality of the labia minora (HP:0012880) | 1.66988375 |
129 | Acute encephalopathy (HP:0006846) | 1.65953732 |
130 | Hypoplasia of the corpus callosum (HP:0002079) | 1.65627265 |
131 | Myelomeningocele (HP:0002475) | 1.59265608 |
132 | Protruding tongue (HP:0010808) | 1.57870082 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K9 | 3.54930447 |
2 | NTRK3 | 3.48218334 |
3 | MARK1 | 3.37581205 |
4 | MAP3K4 | 3.09509151 |
5 | CASK | 2.93397781 |
6 | MAP3K12 | 2.87423732 |
7 | PINK1 | 2.82232927 |
8 | MINK1 | 2.65540175 |
9 | MAP2K7 | 2.63122861 |
10 | GRK5 | 2.57025828 |
11 | KSR2 | 2.29123878 |
12 | NTRK1 | 2.10645872 |
13 | MAP2K4 | 1.99141951 |
14 | PNCK | 1.98662167 |
15 | MAPK13 | 1.93933054 |
16 | RIPK4 | 1.83499213 |
17 | PAK6 | 1.83128712 |
18 | BMPR1B | 1.72228544 |
19 | ERBB3 | 1.68999353 |
20 | PHKG1 | 1.68971340 |
21 | PHKG2 | 1.68971340 |
22 | NTRK2 | 1.64951302 |
23 | LIMK1 | 1.61927438 |
24 | UHMK1 | 1.54260871 |
25 | LMTK2 | 1.53452801 |
26 | MAP3K2 | 1.52573796 |
27 | DAPK2 | 1.47708109 |
28 | ARAF | 1.41442254 |
29 | CDK5 | 1.38310288 |
30 | SGK223 | 1.34013930 |
31 | SGK494 | 1.34013930 |
32 | RET | 1.23169076 |
33 | FES | 1.22474935 |
34 | FER | 1.21686216 |
35 | CDK14 | 1.18356477 |
36 | STK39 | 1.17516055 |
37 | LATS2 | 1.17077536 |
38 | CSNK1G2 | 1.14115988 |
39 | PLK2 | 1.10846771 |
40 | EPHA4 | 1.08724716 |
41 | DYRK2 | 1.03311986 |
42 | CAMK2A | 1.02821524 |
43 | TNIK | 1.02555309 |
44 | ACVR1B | 1.02142724 |
45 | PRKCG | 1.01646702 |
46 | STK11 | 0.97329294 |
47 | MAPKAPK5 | 0.97156399 |
48 | CSNK1G3 | 0.95872666 |
49 | TRIM28 | 0.95686162 |
50 | BCR | 0.94585430 |
51 | CDK18 | 0.93817336 |
52 | EPHA3 | 0.92911980 |
53 | SIK2 | 0.91618214 |
54 | CAMK1D | 0.90377125 |
55 | CDK15 | 0.90355378 |
56 | OXSR1 | 0.90297297 |
57 | TYRO3 | 0.89420960 |
58 | DYRK3 | 0.89167794 |
59 | PRKCE | 0.83863227 |
60 | PAK3 | 0.82852180 |
61 | CDK11A | 0.80605949 |
62 | KSR1 | 0.80238694 |
63 | WNK1 | 0.79735941 |
64 | SGK2 | 0.79420217 |
65 | ADRBK1 | 0.77350636 |
66 | CSNK1A1L | 0.77260648 |
67 | PRKD3 | 0.77031228 |
68 | CAMK2D | 0.75525375 |
69 | CAMK2B | 0.75097679 |
70 | PKN1 | 0.74761297 |
71 | NME1 | 0.74158365 |
72 | RPS6KA2 | 0.72523882 |
73 | ROCK2 | 0.70530207 |
74 | MAP2K1 | 0.69028581 |
75 | CCNB1 | 0.68985033 |
76 | DYRK1A | 0.68175139 |
77 | MAP3K1 | 0.67712028 |
78 | PRKCH | 0.66781848 |
79 | CDK19 | 0.66707166 |
80 | WNK4 | 0.65490391 |
81 | EPHB2 | 0.63612532 |
82 | ERBB4 | 0.63455673 |
83 | PRKCZ | 0.63217754 |
84 | FGFR2 | 0.62547658 |
85 | CDK3 | 0.61974042 |
86 | CAMK1G | 0.61818711 |
87 | CAMK2G | 0.60328121 |
88 | SIK3 | 0.59568401 |
89 | MARK3 | 0.59406930 |
90 | GRK7 | 0.58381206 |
91 | DAPK1 | 0.58055883 |
92 | FRK | 0.57120870 |
93 | MARK2 | 0.56973028 |
94 | TAOK1 | 0.56052103 |
95 | MAP4K2 | 0.54034221 |
96 | ADRBK2 | 0.53784650 |
97 | MAPK12 | 0.52151953 |
98 | CAMK1 | 0.51611755 |
99 | PRKACA | 0.51181882 |
100 | CSNK1G1 | 0.50852692 |
101 | CSNK1E | 0.48271699 |
102 | CAMKK2 | 0.48085993 |
103 | RPS6KA3 | 0.46810743 |
104 | GRK1 | 0.46441670 |
105 | SGK1 | 0.45973978 |
106 | MAPK10 | 0.45092089 |
107 | CAMKK1 | 0.44607729 |
108 | MAPK15 | 0.43236965 |
109 | STK38 | 0.43193976 |
110 | YES1 | 0.42786545 |
111 | RAF1 | 0.42727935 |
112 | CDC42BPA | 0.40451132 |
113 | TSSK6 | 0.40233263 |
114 | WNK3 | 0.40194518 |
115 | SGK3 | 0.39964518 |
116 | PRKCB | 0.39839347 |
117 | FYN | 0.39334255 |
118 | CSNK1D | 0.38864516 |
119 | CSNK1A1 | 0.38742449 |
120 | BRAF | 0.38716671 |
121 | SIK1 | 0.38368084 |
122 | * PRKCA | 0.37822812 |
123 | PRKG1 | 0.37793394 |
124 | ROCK1 | 0.37763288 |
125 | PRKDC | 0.37480581 |
126 | CAMK4 | 0.36316426 |
127 | ERBB2 | 0.36041709 |
128 | PRKACB | 0.34702587 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.90917132 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.79681444 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57575077 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.55135723 |
5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.45905593 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.32790499 |
7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.25920383 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.21817879 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.20156164 |
10 | Taste transduction_Homo sapiens_hsa04742 | 2.11249998 |
11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.10284329 |
12 | Phototransduction_Homo sapiens_hsa04744 | 2.07337035 |
13 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.04467886 |
14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.95720727 |
15 | Olfactory transduction_Homo sapiens_hsa04740 | 1.94309859 |
16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88442396 |
17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.85328449 |
18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.84480207 |
19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.82041785 |
20 | Insulin secretion_Homo sapiens_hsa04911 | 1.80390869 |
21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.73815752 |
22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71869695 |
23 | Salivary secretion_Homo sapiens_hsa04970 | 1.71169910 |
24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.70910337 |
25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.63959562 |
26 | Long-term depression_Homo sapiens_hsa04730 | 1.63700576 |
27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55987187 |
28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52864469 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51936758 |
30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.51391349 |
31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48122781 |
32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39820804 |
33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.36427228 |
34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.32987562 |
35 | Protein export_Homo sapiens_hsa03060 | 1.31909332 |
36 | Axon guidance_Homo sapiens_hsa04360 | 1.31661190 |
37 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.31566281 |
38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.30081035 |
39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29012153 |
40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29009724 |
41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.23991292 |
42 | Renin secretion_Homo sapiens_hsa04924 | 1.21295670 |
43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.17445723 |
44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16909932 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14367633 |
46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13797937 |
47 | Gap junction_Homo sapiens_hsa04540 | 1.13609125 |
48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09779800 |
49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08880144 |
50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99719908 |
51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95370080 |
52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91599275 |
53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80885667 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80132284 |
55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79564803 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78401882 |
57 | Melanogenesis_Homo sapiens_hsa04916 | 0.77389203 |
58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74261445 |
59 | Phagosome_Homo sapiens_hsa04145 | 0.73426468 |
60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72738889 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72698996 |
62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72164327 |
63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71488313 |
64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71155585 |
65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70276946 |
66 | Glioma_Homo sapiens_hsa05214 | 0.68303782 |
67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68113612 |
68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67987482 |
69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67640728 |
70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63135153 |
71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61309727 |
72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57294218 |
73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56349554 |
74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53673289 |
75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53405908 |
76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52470169 |
77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51637062 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51172509 |
79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50078769 |
80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49654859 |
81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46050277 |
82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45644362 |
83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44041921 |
84 | Alcoholism_Homo sapiens_hsa05034 | 0.44033414 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43906358 |
86 | Melanoma_Homo sapiens_hsa05218 | 0.43852825 |
87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42744798 |
88 | Endocytosis_Homo sapiens_hsa04144 | 0.40521503 |
89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39783563 |
90 | Mineral absorption_Homo sapiens_hsa04978 | 0.39236823 |
91 | Bile secretion_Homo sapiens_hsa04976 | 0.38366334 |
92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38091831 |
93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38061927 |
94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37939744 |
95 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36728962 |
96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36512757 |
97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36339798 |
98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36114380 |
99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33162383 |
100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.33108757 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33074613 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30592651 |
103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30450890 |
104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30017595 |
105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29877713 |
106 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29750033 |
107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29367125 |
108 | Prion diseases_Homo sapiens_hsa05020 | 0.28311105 |
109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28261623 |
110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27968415 |
111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27293877 |
112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27145014 |
113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26846435 |
114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25182932 |
115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22699849 |
116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20734439 |
117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19009688 |
118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18952161 |
119 | Tight junction_Homo sapiens_hsa04530 | 0.16959044 |
120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.16085534 |